Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

imiquimod Topical Cream [Aldara]

National Institutes of Health

Related topics

Related topics

3 relations
AldaraTopical Cream

Narrower (1)

imiquimod 50 MG/ML Topical Cream [Aldara]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Evaluation of the treatment costs and duration of topical treatments for multiple actinic keratosis based on the area of the cancerization field and not on the number of lesions
The cost of topical treatments for actinic keratosis (AK) has historically been evaluated in relation to the number of lesions… Expand
Review
2018
Review
2018
[Cytopenia under topical imiquimod in two patients treated with oral hydroxyurea].
BACKGROUND Aldara® is a topical immunomodulatory treatment. The risks of systemic passage are minimal. There have been rare… Expand
2017
2017
Does imiquimod pretreatment optimize 308‐nm excimer laser (UVB) therapy in psoriasis patients?
Psoriasis continues to be a debilitating skin disease affecting 1–3% of the United States population. Although the effectiveness… Expand
2017
2017
Successful treatment of proliferative verrucous leukoplakia with 5% topical imiquimod
Proliferative verrucous leukoplakia (PVL), an entity described by Hansen, Olson, and Silverman (1985), is an uncommon disease of… Expand
2011
2011
Treatment of Verrucous Carcinoma of the Lower Lip with Topical Imiquimod (Aldara®) and Debulking Therapy
Verrucous carcinoma is an unusual, non-metastasizing, distinct variant of squamous cell carcinoma composed of four subtypes… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2011
2011
P076. Sequential treatment with MAL-PDT and imiquimod (Aldara®) in difficult-to-treat basal cell carcinomas: long-term outcome
Discussion: Several hamartomas and neoplasms may arise in conjecture with NSJ, sometimes misleading the pathologist: basaloid… Expand
2010
2010
The efficacy of imiquimod 5% cream (Aldara® in the treatment of aural plaque in horses: a pilot open-label clinical trial.
Aural plaques affect at least 22% of horses and can be asymptomatic or cause ear sensitivity. Immunohistochemical and electron… Expand
  • table 1
  • figure 1
  • figure 2
Review
2006
Review
2006
Therapeutic use of Aldara™ in chronic myeloid leukemia
The potent clinical responses seen in patients with chronic myeloid leukemia (CML) after administration of donor-specific… Expand
2005
2005
PSN2 COST-EFFECTIVENESS ANALYSIS: ALDARA™ (IMIQUIMOD) CREAM, 5% IN THE TREATMENT OF SUPERFICIAL BASAL CELL CARCINOMA IN NORWAY
Review
2003
Review
2003
New Approaches to the Treatment of Actinic Keratosis
Actinic keratoses are hyperkeratotic skin lesions that represent focal abnormal proliferation of epidermal keratinocytes. The… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE